Therapeutic potential and possible risks of pleiotropic growth factors in ischemic stroke

Stroke

Volumn 39, Issue 11, 2008, Pages

  Hermann, Dirk M ^a   Kilic, Ertugrul ^b  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b YEDITEPE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; VASCULOTROPIN;

ANGIOGENESIS; BRAIN ATROPHY; BRAIN EDEMA; BRAIN ISCHEMIA; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CLINICAL EVALUATION; DISEASE EXACERBATION; INFLAMMATION; LETTER; NEUROLOGIC DISEASE; NONHUMAN; PLEIOTROPY; PRIORITY JOURNAL; SEVERE COMBINED IMMUNODEFICIENCY; ANIMAL; HUMAN; META ANALYSIS; MOUSE; MOUSE STRAIN; NOTE; PATHOLOGY; RAT; RISK FACTOR; STROKE; TRANSGENIC MOUSE;

ANIMALS; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; META-ANALYSIS AS TOPIC; MICE; MICE, INBRED STRAINS; MICE, TRANSGENIC; RATS; RISK FACTORS; STROKE;

EID: 55749115082     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.108.532374     Document Type: Letter

References (4)

1. Minnerup J, Heidrich J, Wellmann J, Rogalewski A, Schneider A, Schäbitz WR. Meta-analysis of the efficacy of granulocyte-colony stimulating factor in animal models of focal cerebral ischemia. Stroke. 2008;39:1855-1861.
2. Taguchi A, Wen Z, Myojin K, Yoshihara T, Nakagomi T, Nakayama D, Tanaka H, Soma T, Stern DM, Naritomi H, Matsuyama T. Granulocyte colony-stimulating factor has a negative effect on stroke outcome in a murine model. Eur J Neurosci. 2007;26:126-133.
3. Meisel C, Schwab JM, Prass K, Meisel A, Dirnagl U. Central nervous system injury-induced immune deficiency syndrome. Nat Rev Neurosci. 2005;6:775-786.
4. Kilic E, Kilic U, Wang Y, Bassetti CL, Marti HH, Hermann DM. The phosphatidylinositol-3 kinase/Akt pathway mediates VEGF's neuropro-tective activity and induces blood brain barrier permeability after focal cerebral ischemia. FASEB J. 2006;20:1185-1187.